Background: Acute intermittent porphyria (AIP), an autosomal dominant inborn error, results from the halfnormal activity of the heme biosynthetic enzyme hydroxymethylbilane synthase (EC 4.3.1.8; HMB-synthase). This disease is characterized by acute, lifethreatening neurologic attacks that are precipitated by various drugs, hormones, and other factors. The enzymatic and/or biochemical diagnosis of AIP heterozygotes is problematic; therefore, efforts have focused on the identification of HMB-synthase mutations so that heterozygotes can be identified and educated to avoid the precipitating factors. In Spain, the occurrence of AIP has been reported, but the nature of the HMB-synthase mutations causing AIP in Spanish families has not been investigated. Molecular analysis was therefore undertaken in nine unrelated Spanish AIP patients. Materials and Methods: Genomic DNA was isolated from affected probands and family members of nine unrelated Spanish families with AIP. The HMB-synthase
Introduction
Acute intermittent porphyria (AIP), an autosomal dominant inborn error of metabolism, results from the half-normal activity of hydroxymethylbilane synthase (EC 4.3.1.8; HMB-synthase), the pertension, tachycardia, and various peripheral and central nervous system manifestations. Expression of the disease is highly variable, determined in part by environmental, metabolic, and hormonal factors that induce hepatic 6-aminolevulinic acid synthase activity, the first and ratelimiting enzyme of heme biosynthesis, thereby increasing the production of the porphyrin precursors 8-aminolevulinic acid (ALA) and PBG (1, 2) . The half-normal hepatic HMB-synthase activity in AIP patients is insufficient to prevent precipitation of acute attacks of the disease. Thus, diagnosis of AIP heterozygotes is crucial as the primary form of medical management in the avoidance of specific precipitating factors.
Two major subtypes of AIP have been delineated. In classical AIP, the HMB-synthase activity is half-normal in all cells and tissues, whereas in variant AIP (representing --5% of AIP families), the non-erythroid tissues have half-normal activity, but the enzyme in erythrocytes is expressed at normal levels (1, 3) . Symptomatic heterozygotes with classical or variant AIP, which excrete increased levels of the porphyrin precursors ALA and PBG, can be identified easily, provided that the diagnosis is considered. However, the biochemical diagnosis of asymptomatic heterozygotes, which usually have normal levels of urinary ALA and PBG, has been problematic by enzyme assay, primarily because of the significant overlap between high heterozygote and low normal values (4, 5) . Moreover, identification of asymptomatic heterozygotes for variant AIP is not feasible since they have normal erythrocyte enzymatic activities. In view of the difficulties with biochemical diagnosis, investigators have turned to molecular techniques to identify specific mutations in the HMB-synthase gene for accurate diagnosis of affected members in AIP families.
For the precise diagnosis of AIP, efforts have been directed toward identifying the specific mutation in the HMB-synthase gene in each AIP family. The entire 10 kb HMB-synthase gene has been sequenced, including the 5' regulatory, 3' untranslated, and intronic regions (6) . The gene contains 15 exons and 2 distinct promoters that generate housekeeping and erythroid-specific transcripts by alternative splicing (7, 8) . The housekeeping promoter is in the 5' flanking region and its transcript contains exons 1 and 3 through 15, while the erythroid-specific promoter is in intron 1 and its transcript is encoded by exons Table 1 , the diagnosis of AIP was confirmed in each proband by determining their erythroid HMB-synthase activity and/or levels of urinary ALA, PBG, and porphyrins (13, 14) . Genomic DNA was extracted from peripheral blood using the Puregene DNA isolation kit (Gentra Systems, Minneapolis MN).
Long-Range PCR
The entire HMB-synthase gene (10 kb) was amplified from genomic DNA in two fragments: fragment 1, including the promoter region through intron 3 (4.5 kb PCR product), and fragment 2, containing exon 2 through exon 15 (5.5 kb PCR product) as previously described (11 
Prokaryotic Expression of HMB-Synthase Mutations
The normal and M212V HMB-synthase alleles were individually expressed in E. coli using the pK(K(223-2 vector (Pharmacia Biotech., Piscataway, NJ) as described previously (11, 15) . To introduce the mutations into the normal pKK-HMB-synthase (pKK-HMBS) expression construct, site-directed mutagenesis was performed (16) with the mutation being introduced into the construct by PCR amplification. For the M212V mutation, sense and antisense primers CS52 (5'-GAGTTCAGTGCCATCATCCTGGCAACAGCTGGC-CTGCAGCGCATGGGCTGGCACAACCGGGTTGG-GCAGATCCTGCACCCTGAGGAATGCGTGTAT-3') and CS53 (5'-GCTATCTGAGCCGTCTAGACTCCA-GACTCCT-3') were used to generate a 326 bp amplification product. The reaction was performed in a final volume of 100 ,ul containing lOx Tns-HCl buffer, pH 8.3 (10 ,l), 1 mM of MgCl2, 200 ,aM of 
Results
Molecular analysis of the HMB-synthase gene was performed in nine unrelated Spanish AIP probands. Three new and five previously reported mutations were identified by longrange PCR and cycle sequencing ( Table 2 ). The three novel mutations included a missense mutation (M212V), a single base insertion (g471 SinsT), and a deletion/insertion mutation (g7902ACT ->G). The M212V mutation resulted from an Ato-G transition of genomic nt g7104 in exon 11 predicting the substitution of a neutral hydrophobic valine for a neutral hydrophobic methionine (Fig. 1 A) . This substitution was isofunctional and occurred in a region that was not phylogenetically conserved. To further characterize this base substitution, a pKK-HMBS expression vector containing M212V was constructed, and expressed in E. coli, and the enzymatic activity of the mutant protein was determined. As shown in Table 3 , the residual enzymatic activity of the mutant protein was 1.7% of the mean enzymatic activity expressed by the normal allele, indicating that the base substitution was indeed a causative missense mutation.
The second novel mutation was the insertion of a single thymidine at genomic nt 4715 (cDNA nt 340) in exon 7, which resulted in a frameshift that predicted substitution of seven amino acids in codons 114 to 120 (1 14CKRENPH->l 14LQAGKPSX) and chain termination (codon 121), thereby deleting the last two-thirds of the 361 amino acids of the monomeric housekeeping isoenzyme (Fig. LB) . The third novel mutation was a deletion/insertion in exon 14 at genomic nt g7902 (cDNA nt 835), involving the deletion of the three nucleotides ACT, and their replacement by a single G (Fig. 1C) . This deletion/insertion resulted in a frameshift and predicted the replacement of the next nine amino acids in codons 279 to 289 (279TGGVWSLDGS by 279GRSLESRRLRX) prior to termination at codon 289, thereby deleting the last 73 amino acids of the housekeeping isoenzyme.
In the remaining six Spanish AIP families, each had a previously reported mutation. These included one nonsense and four missense muta- (12) . The cause of the high frequency of RI 16W in the Dutch population was unclear, as there was no common ancestor among the Dutch AIP patients for at least four generations, nor were the patients haplotyped (12) . Mutation R149X was first reported in a Finnish patient (21) , RI 67W in an English homozygous AIP patient and in a Dutch patient (22, 23) , while R173W was initially identified in a Scottish AIP patient (24) . Subsequent to these reports, each of these mutations have been detected in AIP patients from other ethnic groups (5, 25) .
Purified HMB-synthase from E. coli has been crystalized, and the structure has been determined to 1.9A resolution (26) . The crystal structure revealed three domains, each comprising ,3-sheets, an a-helical secondary structure, and a discrete hydrophobic core. Since the E. coli and human HMB-synthase amino acid sequences have about 35% amino acid identity and more than 70% similarity, it is possible to infer structure-function relationships for certain human HMB-synthase mutations (27) . Four of the previously reported mutations (RI16W, R149X, R167W, and R173W) involve the replacement of invariant arginines that are important for the enzyme's structure and function (27) . Ri 16 is involved in an interdomain salt bridge and its replacement by a tryptophan renders the enzyme less stable, while mutation R149X would truncate the terminal 210 amino acids, including about 15 residues in domain 1, about 63 residues in domain 2, and all 132 residues in domain 3 (27) . Mutations R167W and R173W replace arginines involved in critical salt bridges that stabilize interactions with the acetate and propionate side groups of the dipyrromethane cofactor in the active site. R167 interacts with a ring C2 side chain when the cofactor pyrrole ring occupies the putative substrate binding site and RI 73 similarly interacts with the side chains of rings Ci and C2 of the cofactor (27) . The insertion/ deletion mutation may affect the attachment of the dipyrromethane cofactor to domain 3 of the HMB-synthase protein (28) . Mutation M212V is located in a loop region connecting the f4 and ,B5 sheets of domain 1 and may result in loss of its mobility, which is required for the entry of successive substrate molecules (26) .
In summary, the first HMB-synthase mutations causing AIP in nine unrelated Spanish probands were identified, including three novel and five previously reported mutations, four of the later involving known mutational hotspots in the gene. The finding of eight mutations in nine families highlights the molecular heterogeneity underlying AIP, enables the precise diagnosis of asymptomatic heterozygotes in these Spanish families, and provides additional information for future structure-function studies of the human enzyme.
